<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02837874</url>
  </required_header>
  <id_info>
    <org_study_id>2016-02-052</org_study_id>
    <nct_id>NCT02837874</nct_id>
  </id_info>
  <brief_title>Comparisons Between Isoperistaltic and Antiperistaltic Gastrojejunostomy in Laparoscopic Distal Gastrectomy</brief_title>
  <official_title>Comparisons Between Isoperistaltic and Antiperistaltic Gastrojejunostomy in Laparoscopic Distal Gastrectomy, Randomized Prospective Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Keimyung University Dongsan Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Keimyung University Dongsan Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Billroth-II (gastrojejunostomy) is one of major option after gastrectomy for gastric cancer.
      The investigators hypothesized that isoperistaltic anastomosis lead to higher incidence of
      dumping syndrome but antiperistaltic (anisoperistaltic) anastomosis have relevance to gastric
      stasis or obstruction. The investigators will assess complications, dumping syndrome and
      quality of life between isoperistaltic and antiperistaltic after distal gastrectomy for
      gastric cancer.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Recently, laparoscopic approach has been a option for gastric cancer, especially early
      gastric cancer. There are growing interest in quality of life in addition to recurrence or
      survival. There are few report about peristalsis and no report for quality of life according
      to a direction of peristalsis.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2016</start_date>
  <completion_date type="Anticipated">March 2019</completion_date>
  <primary_completion_date type="Anticipated">March 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Dumping syndrome</measure>
    <time_frame>12 months</time_frame>
    <description>Using Sigstad's score</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>long-term complication</measure>
    <time_frame>from 1 month to 12 months</time_frame>
    <description>all kind of complication</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total score of quality of life questionnaire</measure>
    <time_frame>12 months</time_frame>
    <description>by EORTC questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body weight change</measure>
    <time_frame>12 months</time_frame>
    <description>for evaluate nutritional status</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgical complication</measure>
    <time_frame>within 1 month</time_frame>
    <description>all kind of complication within 1 month</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gastritis</measure>
    <time_frame>12 months</time_frame>
    <description>by endoscopic evaluation</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Stomach Neoplasms</condition>
  <arm_group>
    <arm_group_label>Isoperistaltic</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Same direction of peristalsis between stomach and jejunum, efferent loop of jejunum is located on the distal part of remnant stomach</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Antiperistaltic</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Reverse direction of peristalsis between stomach and jejunum, efferent loop of jejunum is located on the proximal part of remnant stomach</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Isoperistaltic</intervention_name>
    <description>Same direction of peristalsis between stomach and jejunum, efferent loop of jejunum is located on the distal part of remnant stomach</description>
    <arm_group_label>Isoperistaltic</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Antiperistaltic</intervention_name>
    <description>Reverse direction of peristalsis between stomach and jejunum, efferent loop of jejunum is located on the proximal part of remnant stomach</description>
    <arm_group_label>Antiperistaltic</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Histologically confirmed adenocarcinoma in stomach

          -  Scheduled as laparoscopic distal gastrectomy (tumor located lower or middle third)

          -  Planned with gastrojejunostomy after gastrectomy

          -  Clinical stage T1N0M0 or T2N0M0

          -  ECOG 0 or 1 (The Eastern Cooperative Oncology Group)

          -  ASA score class I-III (The American Society of Anesthesiologists)

          -  patient has given their written informed consent to participate in the study

        Exclusion Criteria:

          -  Simultaneously combined resection of other organ (including cholecystectomy)

          -  Active other malignancy

          -  Requiring total gastrectomy

          -  Chronic inflammatory bowel disease or other chronic disease related to bowel motility

          -  Uncontrolled diabetes or patients with diabetic complications

          -  Vulnerable patients
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Seung Wan Ryu, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Keimyung University Dongsan Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Seung Wan Ryu, M.D., Ph.D.</last_name>
    <phone>82-53-250-7322</phone>
    <email>gsman@dsmc.or.kr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Keimyung University Dongsan Medical Center</name>
      <address>
        <city>Daegu</city>
        <zip>700-712</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Seung Wan Ryu, MD, PhD</last_name>
      <phone>82-53-250-7322</phone>
      <email>gsman@dsmc.or.kr</email>
    </contact>
    <contact_backup>
      <last_name>In Gyu Kwon, MD</last_name>
      <phone>82-53-250-7322</phone>
      <email>surgeon@dsmc.or.kr</email>
    </contact_backup>
    <investigator>
      <last_name>Seung Wan Ryu, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>In Gyu Kwon, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Young Gil Son, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <results_reference>
    <citation>Banerjee A, Ding Y, Mikami DJ, Needleman BJ. The role of dumping syndrome in weight loss after gastric bypass surgery. Surg Endosc. 2013 May;27(5):1573-8. doi: 10.1007/s00464-012-2629-1. Epub 2012 Dec 12.</citation>
    <PMID>23233009</PMID>
  </results_reference>
  <results_reference>
    <citation>Bergamaschi R, Arnaud JP, MÃ¥rvik R, Myrvold HE. Laparoscopic antiperistaltic versus isoperistaltic gastrojejunostomy for palliation of gastric outlet obstruction in advanced cancer. Surg Laparosc Endosc Percutan Tech. 2002 Dec;12(6):393-7.</citation>
    <PMID>12496544</PMID>
  </results_reference>
  <results_reference>
    <citation>Mine S, Sano T, Tsutsumi K, Murakami Y, Ehara K, Saka M, Hara K, Fukagawa T, Udagawa H, Katai H. Large-scale investigation into dumping syndrome after gastrectomy for gastric cancer. J Am Coll Surg. 2010 Nov;211(5):628-36. doi: 10.1016/j.jamcollsurg.2010.07.003. Epub 2010 Sep 15.</citation>
    <PMID>20829078</PMID>
  </results_reference>
  <results_reference>
    <citation>Houghton AD, Liepins P, Clarke S, Mason R. Iso- or antiperistaltic anastomosis: does it matter? J R Coll Surg Edinb. 1996 Jun;41(3):148-51.</citation>
    <PMID>8763175</PMID>
  </results_reference>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 8, 2016</study_first_submitted>
  <study_first_submitted_qc>July 15, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 20, 2016</study_first_posted>
  <last_update_submitted>November 12, 2017</last_update_submitted>
  <last_update_submitted_qc>November 12, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Keimyung University Dongsan Medical Center</investigator_affiliation>
    <investigator_full_name>Seung Wan Ryu</investigator_full_name>
    <investigator_title>Director of Gastrointesinal surgery, professor</investigator_title>
  </responsible_party>
  <keyword>Gastric cancer</keyword>
  <keyword>gastrojejunostomy</keyword>
  <keyword>isoperistaltic</keyword>
  <keyword>antiperistaltic</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stomach Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Antidiarrheals</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

